Health Canada approves MSD’s Keytruda for NSCLC stages
Health Canada has approved MSD's anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...
Cure Today1d
THIO and Libtayo Extends OS in NSCLC Following Progression on SOC Therapy
THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...
The American Journal of Managed Care12d
Small Cell Lung Cancer
Patients with extensive-stage small cell lung cancer (ES-SCLC ... to treat patients with resectable non–small cell lung cancer (NSCLC) as a neoadjuvant treatment with chemotherapy and continued ...
pulmonologyadvisor1d
Survival Improved With Lobectomy, Segmentectomy in Early NSCLC
For patients with stage IA NSCLC, lung resections, including lobectomy and segmentectomy, are associated with improved long-term survival compared with wedge resection.
EurekAlert!6d
New genetic mutation linked to drug resistance in non-small cell lung cancer patient
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...
Healio11d
Survival better with lobectomy vs. wedge resection in early stage lung cancer
Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs.
Revolutionizing Lung Cancer Treatment
With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...